scholarly journals Prevalence of Type II Diabetes Mellitus Among Adult Population in Medical Department of A Tertiary Care Centre

2020 ◽  
Vol 58 (232) ◽  
Author(s):  
Lochan Karki ◽  
Krishna Rana ◽  
Manisha Shahi ◽  
Anjila Pradhan ◽  
Roshina Thapa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Care Center ◽  
Adult Population ◽  
Tertiary Care ◽  
Type Ii Diabetes Mellitus ◽  
Ethical Review ◽  
Type Ii ◽  
Tertiary Care Center ◽  
Medical Department

Introduction: Diabetes mellitus is a chronic metabolic disease that is mainly associated with a number of lifestyle behaviors. There is a high discrepancy among urban and rural populations with the prevalence of diabetes in rural areas as 2.5% and a high prevalence of 14.6% in urban areas. Type 2 diabetes mellitus accounts for the majority of all diabetes cases with a number of chronic effects that include cardiovascular disease, kidney disease, blindness, and disability. This study is done to determine the prevalence of Type II Diabetes Mellitus among the adult population in the medical department of a tertiary care center. Methods: A descriptive cross-sectional study was done in a medical department of a tertiary care center of Himal Hospital Private Limited from March to April 2020. Ethical approval was taken from the Ethical Review Board of NHRC (Reference Number 752). All the data of the last two years from the medical record section were included in the study. The convenience sampling technique was followed. Descriptive statistical analysis was done. Results: The study showed the prevalence of Type II Diabetes Mellitus among the adult population to be 23.93 % (0.23) (C.I= 0.20-0.26). Prevalence was found to be ... Conclusions: The prevalence of Type II Diabetes Mellitus was found to be higher than the previous study done in similar settings.

scholarly journals Mean Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus Attending Tertiary Care Center: A Descriptive Cross-sectional Study

2021 ◽  
Vol 59 (244) ◽  
pp. 1243-1246
Author(s):  
Prakash Kayastha ◽  
Sharma Paudel ◽  
Ghanshyam Gurung ◽  
Pradeep Kumar ◽  
Rudra Prasad Upadhyaya ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Care Center ◽  
Tertiary Care ◽  
Intima Media Thickness ◽  
Carotid Intima Media Thickness ◽  
Type Ii Diabetes Mellitus ◽  
Diabetic Patients ◽  
Type Ii ◽  
Media Thickness

Introduction: Sonographic carotid intima media thickness measurement in diabetic patients is an important tool for estimating the risk of cardiovascular and cerebrovascular events. It is a simple, noninvasive and widely available tool which can give idea of further treatment needed. The objective of this study was to determine the mean intima media complex thickness in patients with type II diabetes mellitus attending a tertiary care center. Methods: This was a descriptive cross-sectional study done in 64 patients with the type II diabetes mellitus patients visiting diabetic clinic of Tribhuvan University Teaching Hospital, sent for carotid Doppler examination in the department of radiology and imaging. Ethical approval was taken from the Instituitonal Review Board. Convenient sampling method was used. Carotid intima media thickness was measured on both sides and mean intima media thickness was calculated. Mean intima media thickness for male and female diabetic patients was also calculated separately. Statistical Package for Social Sciences version 25 was used for data analysis. Results: The mean carotid intima media thickness was 0.86±0.13mm with range from 0.7mm to 1.3mm. Mean intima media thickness in male was 0.832±0.094mm and in female it was 0.904±0.144mm. Among 64 patients, 30 (46.8%) were female and 34 (53.3%) were male. Age of the patients ranged from 35 years to 68 years with mean age of 52.4±6.54 years. Conclusions: Carotid intima media thickness in patients with type II diabetes mellitus showed higher values than that of mean value from study done in similar study. Female had higher mean intima media thickness than male.

scholarly journals PREVALENCE OF SILENT CARDIAC ISCHEMIA IN TYPE II DIABETES MELLITUS

2021 ◽  
Vol 54 (2) ◽  
pp. 162-166
Author(s):  
Nosheen Zia ◽  
Sabeen Aftab ◽  
Nauman Ismat Butt ◽  
Fahmina Ashfaq ◽  
Aniqa Anser ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Body Mass Index ◽  
Body Mass ◽  
Type Ii Diabetes ◽  
Tertiary Care ◽  
Care Facility ◽  
Type Ii Diabetes Mellitus ◽  
Cardiac Ischemia ◽  
Type Ii ◽  
Tertiary Care Facility

Objectives: To determine the frequency of silent cardiac ischemia in type II diabetes mellitus patients presenting to tertiary care facility. Methodology: This cross-sectional study was conducted from 20th October 2017 to 20th April 2018 at Department of Medicine Jinnah Hospital Lahore. After a detailed history, measurement of height, blood pressure, weight, fasting blood sugar, body mass index of 237 patients were recorded, and electrocardiography (ECG) was done before and after exercise tolerance testing (ETT). Changes in ECG were assessed and person labeled as having silent cardiac ischemia or not depending on the outcome of the ECG. Results: Mean age was 54.9 ± 5.9 (range: 45 – 63) years. There were 144 male patients and 93 female patients The mean duration of type II diabetes mellitus in the study population was 10.0 ± 2.6 (range: 6 – 15) years. The frequency of silent cardiac ischemia was found to be 45.1%. Increasing age, prolonged duration of diabetes mellitus, history of smoking and hypertension, and increased body mass index were significantly related to silent cardiac ischemia (p-value< 0.05). Conclusion: Silent cardiac is quite prevalent in our population that demands urgent efforts to diagnose this condition earlier for better future outcomes.

scholarly journals A Clinical Pharmacological Study of the Prevalent Prescription Patterns of Metformin, Sitagliptin and Gemigliptin among the Early Moderate Grade New Type II Diabetes Mellitus Patients in Global Tertiary Care Hospitals

2021 ◽  
Vol 70 (1) ◽  
Author(s):  
Dr. Moumita Hazra ◽  
Dr. Moumita Hazra
Keyword(s):  
Diabetes Mellitus ◽  
Type Ii Diabetes ◽  
Pharmacological Study ◽  
Tertiary Care ◽  
Type Ii Diabetes Mellitus ◽  
Type Ii ◽  
Once Daily ◽  
Dipeptidyl Peptidase 4 ◽  
New Type ◽  
Tertiary Care Hospitals

Type II diabetes mellitus is a common global hormonal disorder. Inhibition of dipeptidyl peptidase – 4 by dipeptidyl peptidase – 4 inhibitors enhances hormonal activity of incretins, like GLP – 1, GIP, GRP, stimulates insulin release and reduces glucagon secretion, finally producing anti-hyperglycaemic activity in diabetic patients. A clinical pharmacological study of the prevalent prescription patterns of metformin, sitagliptin and gemigliptin among the early moderate grade new type II diabetes mellitus patients in global multi-centre tertiary care hospitals. 100 new early moderate grade type II diabetes mellitus patients, were prescribed oral metformin 500 mg once daily, sitagliptin 25 mg once daily or gemigliptin 25 mg once daily for 3 months, in monotherapy, or in combination therapy, or in a mixed regimen of monotherapy and combination therapy. The safety and efficacy assessments, with blood sugar and HbA1c levels and urine examination, at subsequent intervals and follow-up, were recorded and analysed. The number of prescriptions for each drug was recorded, and the respective prescription rates were statistically analysed in percentages. Metformin was most commonly prescribed (80 prescriptions, 80%), followed by sitagliptin (16 prescriptions, 16%), and gemigliptin (4 prescriptions, 4%). Prescription frequency of metformin was followed by sitagliptin and then by gemigliptin.

scholarly journals Corrigendum to “Five-Year Incidence and Progression of Diabetic Retinopathy in Patients with Type II Diabetes in a Tertiary Care Center in Lebanon”

2018 ◽  
Vol 2018 ◽  
pp. 1-1
Author(s):  
Carl-Joe Mehanna ◽  
Maamoun Abdul Fattah ◽  
Hani Tamim ◽  
Mona P. Nasrallah ◽  
Raya Zreik ◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Type Ii Diabetes ◽  
Care Center ◽  
Tertiary Care ◽  
Type Ii ◽  
Tertiary Care Center
Sign in / Sign up

Export Citation Format

Share Document